IL HB1721 | 2021-2022 | 102nd General Assembly

Illinois House Bill 1721 (Prior Session Legislation)

Status

Sponsorship: Bipartisan Bill
Status: Introduced on February 11 2021 - 25% progression, died in committee
Action: 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Amends the Illinois Food, Drug and Cosmetic Act. Requires a manufacturer of a prescription drug that is sold, offered for sale, or distributed in this State, or placed on a formulary to be eligible for payment, co-payment, or reimbursement in this State, to notify the Department of Public Health of specified information concerning active pharmaceutical ingredients.

Title

PHARMACEUTICAL INGREDIENTS

History

Date	Chamber	Action
2021-04-23	House	Rule 19(a) / Re-referred to Rules Committee
2021-04-14	House	Held on Calendar Order of Second Reading - Short Debate
2021-04-14	House	Removed from Consent Calendar Status Rep. Greg Harris
2021-04-14	House	Added Co-Sponsor Rep. La Shawn K. Ford
2021-04-14	House	Added Co-Sponsor Rep. Ryan Spain
2021-04-14	House	Held on Calendar Order of Second Reading - Consent Calendar
2021-04-14	House	Second Reading - Consent Calendar
2021-04-06	House	Added Chief Co-Sponsor Rep. Carol Ammons
2021-03-18	House	Placed on Calendar 2nd Reading - Consent Calendar
2021-03-15	House	Do Pass / Consent Calendar Consumer Protection Committee; 006-000-000
2021-03-09	House	Added Co-Sponsor Rep. Jonathan Carroll
2021-03-09	House	Assigned to Consumer Protection Committee
2021-02-17	House	Referred to Rules Committee
2021-02-17	House	First Reading
2021-02-11	House	Filed with the Clerk by Rep. Deanne M. Mazzochi

Code Citations

Chapter	Article	Section	Citation Type	Statute Text
410	620	3.24	New Code	See Bill Text

Illinois State Sources

Type	Source
Summary	https://www.ilga.gov/legislation/BillStatus.asp?DocNum=1721&GAID=16&DocTypeID=HB&SessionID=110&GA=102
Text	https://www.ilga.gov/legislation/102/HB/10200HB1721.htm